Cited by 807Nanoparticle-Based Drug DeliveryIron Metabolism and DisordersRNA Interference and Gene Delivery

The DOI matches its Crossref record; 232 of the 232 references it cites were found in a registry or an index.

The transferrin receptor and the targeted delivery of therapeutic agents against cancer

Open access

Daniels, Tracy R., Bernabeu, Ezequiel, Rodríguez, José A., Patel, Shabnum, Kozman, Maggie, Chiappetta, Diego A., Holler, Eggehard, Ljubimova, Julia Y., Helguera, Gustavo, Penichet, Manuel L.·2012·Biochimica et Biophysica Acta (BBA) - General Subjects

DOI 10.1016/j.bbagen.2011.07.016PMC PMC3500658

Open this paper in CoChat — free account

Abstract

Background Traditional cancer therapy can be successful in destroying tumors, but can also cause dangerous side effects. Therefore, many targeted therapies are in development. The transferrin receptor (TfR) functions in cellular iron uptake through its interaction with transferrin. This receptor is an attractive molecule for the targeted therapy of cancer since it is upregulated on the surface of many cancer types and is efficiently internalized. This receptor can be targeted in two ways: 1) for the delivery of therapeutic molecules into malignant cells or 2) to block the natural function of the receptor leading directly to cancer cell death.Scope of review In the present article we discuss the strategies used to target the TfR for the delivery of therapeutic agents into cancer cells. We provide a summary of the vast types of anti-cancer drugs that have been delivered into cancer cells employing a variety of receptor binding molecules including Tf, anti-TfR antibodies, or TfR-binding peptides alone or in combination with carrier molecules including nanoparticles and viruses.Major conclusions Targeting the TfR has been shown to be effective in delivering many different therapeutic agents and causing cytotoxic effects in cancer cells in vitro and in vivo.General significance The extensive use of TfR for targeted therapy attests to the versatility of targeting this receptor for therapeutic purposes against malignant cells. More advances in this area are expected to further improve the therapeutic potential of targeting the TfR for cancer therapy leading to an increase in the number of clinical trials of molecules targeting this receptor. This article is part of a Special Issue entitled Transferrins: molecular mechanisms of iron transport and disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.bbagen.2011.07.016

Cites

232 of 232 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.
Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., & Steinman, R. M. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.6.1693 · Cited by 3,741
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,040
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D. B., Tolcher, A. W., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,541
The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices
Jain, R. A. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00115-0 · Cited by 2,214
Nanomedicine: current status and future prospects
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2747rev · Cited by 2,029
Cyclodextrins and their pharmaceutical applications
Loftsson, Þ., & Duchêne, D. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.10.044 · Cited by 1,766
Polysaccharides-based nanoparticles as drug delivery systems
Liu, Z., Jiao, Y., Wang, Y., Zhou, C., & Zhang, Z. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.001 · Cited by 1,739
Block copolymer micelles: preparation, characterization and application in drug delivery
Gaucher, G., Dufresne, M.-H., Sant, V. P., Kang, N., Maysinger, D., & Leroux, J.-C. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.034 · Cited by 1,498
Dendrimers in Supramolecular Chemistry: From Molecular Recognition to Self-Assembly
Zeng, F., & Zimmerman, S. C. (1997) · Chemical Reviews · doi:10.1021/cr9603892 · Cited by 1,406
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles
Reis, C. P., Neufeld, R. J., Ribeiro, A. J., & Veiga, F. (2006) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2005.12.003 · Cited by 1,355
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
Malam, Y., Loizidou, M., & Seifalian, A. M. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.08.004 · Cited by 1,317
Polymeric micelles—A new generation of colloidal drug carriers
Jones, M.-C., & Leroux, J.-C. (1999) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(99)00039-9 · Cited by 1,256
Cyclodextrin Rotaxanes and Polyrotaxanes
Wenz, G., Han, B., & Müller, A. H. E. (2006) · Chemical Reviews · doi:10.1021/cr970027+ · Cited by 1,245
A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes
Letchford, K., & Burt, H. M. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.11.009 · Cited by 1,200
Dendrimers in drug research
Boas, U., & Heegaard, P. M. H. (2003) · Chemical Society Reviews · doi:10.1039/b309043b · Cited by 1,184
PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery
Ogris, M., Brunner, S., Schüller, S., Kircheis, R., & Wagner, E. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300900 · Cited by 1,178
Micellar Nanocontainers Distribute to Defined Cytoplasmic Organelles
Savić, R., Luo, L., Eisenberg, A., & Maysinger, D. (2003) · Science · doi:10.1126/science.1078192 · Cited by 1,113
The First Targeted Delivery of siRNA in Humans via a Self-Assembling, Cyclodextrin Polymer-Based Nanoparticle: From Concept to Clinic
Davis, M. E. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900015y · Cited by 979
Nanoparticles for drug delivery in cancer treatment
Haley, B., & Frenkel, E. P. (2008) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.03.015 · Cited by 823
The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes
Tang, M., & Szoka, F. C. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300454 · Cited by 814
The Chemotherapy Source Book
(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-5-448_4 · Cited by 787
Application of Nanotechnology in Cancer Therapy and Imaging
Wang, X., Yang, L., Chen, Z., & Shin, D. M. (2008) · CA A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0003 · Cited by 704
Cancer nanotechnology: application of nanotechnology in cancer therapy
Misra, R., Acharya, S., & Sahoo, S. K. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.08.006 · Cited by 701
Engineering targeted viral vectors for gene therapy
Waehler, R., Russell, S. J., & Curiel, D. T. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2141 · Cited by 687
The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems.
Plank, C., Oberhauser, B., Mechtler, K., Koch, C., & Wagner, E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99963-1 · Cited by 666
Chitosan Nanoparticles: A Promising System in Novel Drug Delivery
Nagpal, K., Singh, S. K., & Mishra, D. N. (2010) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.58.1423 · Cited by 661
Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle.
Wagner, E., Plank, C., Zatloukal, K., Cotten, M. L., & Birnstiel, M. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.7934 · Cited by 657
Transferrin-polycation conjugates as carriers for DNA uptake into cells.
Wagner, E., Zenke, M., Cotten, M. L., Beug, H., & Birnstiel, M. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.9.3410 · Cited by 655
Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs
Lukyanov, A. N., & Torchilin, V. P. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.004 · Cited by 654
A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas
Lee, C., Gillies, E. R., Fox, M. E., Guillaudeu, S. J., Fréchet, J. M. J., Dy, E. E., & Szoka, F. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607705103 · Cited by 648
The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer
Daniels‐Wells, T. R., Delgado, T., Rodríguez, J. A., Helguera, G. F., & Penichet, M. L. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.06.010 · Cited by 646
Self-citation
Crystal Structure of the Hemochromatosis Protein HFE and Characterization of Its Interaction with Transferrin Receptor
Lebrón, J. A., Bennett, M. J., Vaughn, D. E., Chirino, A. J., Snow, P. M., Mintier, G. A., Feder, J. N., & Björkman, P. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81151-4 · Cited by 639
Poly(ethylene oxide)–poly(propylene oxide) block copolymer micelles as drug delivery agents: Improved hydrosolubility, stability and bioavailability of drugs
Chiappetta, D. A., & Sosnik, A. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.03.022 · Cited by 579
Self-citation
Structure of the human transferrin receptor-transferrin complex
Cheng, Y., Zak, O., Aisen, P., Harrison, S. C., & Walz, T. (2004) · Cell · doi:10.1016/s0092-8674(04)00130-8 · Cited by 571
Sequence-Specific Knockdown of EWS-FLI1 by Targeted, Nonviral Delivery of Small Interfering RNA Inhibits Tumor Growth in a Murine Model of Metastatic Ewing's Sarcoma
Hu‐Lieskovan, S., Heidel, J. D., Bartlett, D. W., Davis, M. E., & Triche, T. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0565 · Cited by 568
Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't know
Shi, Y., Liu, C. H., Roberts, A. I., Das, J., Xu, G., Ren, G., Zhang, Y., Zhang, L., Yuan, Z., Tan, H. S., et al. (2006) · Cell Research · doi:10.1038/sj.cr.7310017 · Cited by 550
A PEGylated dendritic nanoparticulate carrier of fluorouracil
Bhadra, D., Bhadra, S., Jain, S., & Jain, N. K. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00132-7 · Cited by 544
Dendrimers: Emerging polymers for drug-delivery systems
Nanjwade, B. K., Bechra, H. M., Derkar, G. K., Manvi, F. V., & Nanjwade, V. K. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.07.008 · Cited by 543
Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors
Laske, D. W., Youle, R. J., & Oldfield, E. H. (1997) · Nature Medicine · doi:10.1038/nm1297-1362 · Cited by 522
Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes.
Wagner, E., Zatloukal, K., Cotten, M. L., Kirlappos, H., Mechtler, K., Curiel, D., & Birnstiel, M. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.13.6099 · Cited by 481
The blood-brain and blood-tumor barriers: A review of strategies for increasing drug delivery
Groothuis, D. R. (2000) · Neuro-Oncology · doi:10.1093/neuonc/2.1.45 · Cited by 463
Ligand-targeted liposomal anticancer drugs
Sapra, P., & Allen, T. M. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00032-8 · Cited by 447
Designing dendrimers for drug delivery
Liu, M., & Fréchet, J. M. J. (1999) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(99)00203-5 · Cited by 434
Dendrimers: a new class of nanoscopic containers and delivery devices
Aulenta, F., Hayes, W., & Rannard, S. P. (2003) · European Polymer Journal · doi:10.1016/s0014-3057(03)00100-9 · Cited by 401
Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA
Heidel, J. D., Yu, Z., Liu, J. Y.-C., Rele, S. M., Liang, Y., Zeidan, R. K., Kornbrust, D. J., & Davis, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701458104 · Cited by 390
Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's Sarcoma
Northfelt, D., Martin, F. J., Working, P. K., Volberding, P. A., Russell, J., Newman, M., Amantea, M., & Kaplan, L. D. (1996) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1996.tb04152.x · Cited by 377
Liposomes as delivery systems for antibiotics
Drulis‐Kawa, Z., & Dorotkiewicz‐Jach, A. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.11.033 · Cited by 373
Polycation-based DNA complexes for tumor-targeted gene delivery in vivo
Kircheis, R., Schüller, S., Brunner, S., Ogris, M., Heider, K., Zauner, W., & Wagner, E. (1999) · The Journal of Gene Medicine · doi:10.1002/(sici)1521-2254(199903/04)1:2 · Cited by 358
Transferrin-Containing, Cyclodextrin Polymer-Based Particles for Tumor-Targeted Gene Delivery
Bellocq, N. C., Pun, S. H., Jensen, G. S., & Davis, M. E. (2003) · Bioconjugate Chemistry · doi:10.1021/bc034125f · Cited by 350
Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention
Sahoo, S. K., & Labhasetwar, V. (2005) · Molecular Pharmaceutics · doi:10.1021/mp050032z · Cited by 340
Transferrin-polycation-mediated introduction of DNA into human leukemic cells: stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels.
Cotten, M. L., Längle-Rouault, F., Kirlappos, H., Wagner, E., Mechtler, K., Zenke, M., Beug, H., & Birnstiel, M. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4033 · Cited by 337
Multifunctional Micellar Nanomedicine for Cancer Therapy
Blanco, E., Kessinger, C. W., Sumer, B. D., & Gao, J. (2008) · Experimental Biology and Medicine · doi:10.3181/0808-mr-250 · Cited by 333
The Complex Role of Multivalency in Nanoparticles Targeting the Transferrin Receptor for Cancer Therapies
Wang, J., Tian, S., Petros, R. A., Napier, M. E., & DeSimone, J. M. (2010) · Journal of the American Chemical Society · doi:10.1021/ja1043177 · Cited by 333
Efficacy of transferrin‐conjugated paclitaxel‐loaded nanoparticles in a murine model of prostate cancer
Sahoo, S. K., Ma, W., & Labhasetwar, V. D. (2004) · International Journal of Cancer · doi:10.1002/ijc.20405 · Cited by 327
Development and Brain Delivery of Chitosan−PEG Nanoparticles Functionalized with the Monoclonal Antibody OX26
Aktaş, Y., Yemişçi, M., Andrieux, K., Gürsoy, R. N., Alonso, M. J., Fernández-Megía, E., Novoa-Carballal, R., Quiñoá, E., Riguera, R., Sargon, M. F., et al. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050217o · Cited by 318
Novel Shielded Transferrin−Polyethylene Glycol−Polyethylenimine/DNA Complexes for Systemic Tumor-Targeted Gene Transfer
Kursa, M., Walker, G. F., Roessler, V., Ogris, M., Röedl, W., Kircheis, R., & Wagner, E. (2002) · Bioconjugate Chemistry · doi:10.1021/bc0256087 · Cited by 313
PEGylated Poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors
He, H., Li, Y., Jia, X., Du, J., Ying, X., Lü, W.-L., Lou, J., & Wei, Y. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.09.002 · Cited by 307
Transferrin Receptor Ligand-Targeted Toxin Conjugate (Tf-CRM107) for Therapy of Malignant Gliomas
Weaver, M. W., & Laske, D. W. (2003) · Journal of Neuro-Oncology · doi:10.1023/a:1026246500788 · Cited by 302
Physicochemical and Biological Characterization of Targeted, Nucleic Acid-Containing Nanoparticles
Bartlett, D. W., & Davis, M. E. (2007) · Bioconjugate Chemistry · doi:10.1021/bc0603539 · Cited by 287
Targeted delivery of doxorubicin using stealth liposomes modified with transferrin
Li, X., Ding, L., Xu, Y., Wang, Y., & Ping, Q. N. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.01.023 · Cited by 275
Anti-transferrin receptor monoclonal antibody and toxin–antibody conjugates affect growth of human tumour cells
Trowbridge, I. S., & Domingo, D. L. (1981) · Nature · doi:10.1038/294171a0 · Cited by 275
Liposomes Bearing Polyethyleneglycol-Coupled Transferrin with Intracellular Targeting Property to the Solid Tumors In Vivo
Ishida, O., Maruyama, K., Tanahashi, H., Iwatsuru, M., Sasaki, K., Eriguchi, M., & Yanagië, H. (2001) · Pharmaceutical Research · doi:10.1023/a:1010960900254 · Cited by 258
Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes.
Xu, L., Huang, C., Huang, W., Tang, W., Rait, A. S., Yin, Y. Z., Cruz, I., Xiang, L., Pirollo, K. F., & Chang, E. H. (2002) · PubMed · Cited by 243
Characterization of a monoclonal antibody (5E9) that defines a human cell surface antigen of cell activation.
Haynes, B. F., Hemler, M. E., Cotner, T., et al. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.127.1.347 · Cited by 228
Transferrin-Liposome-Mediated Systemic p53 Gene Therapy in Combination with Radiation Results in Regression of Human Head and Neck Cancer Xenografts
Xu, L., Pirollo, K. F., Tang, W., et al. (1999) · Human Gene Therapy · doi:10.1089/10430349950016357 · Cited by 221
Intracellular targeting therapy of cisplatin‐encapsulated transferrin‐polyethylene glycol liposome on peritoneal dissemination of gastric cancer
Iinuma, H., Maruyama, K., Okinaga, K., Sasaki, K., Sekine, T., Ishida, O., Ogiwara, N., Johkura, K., & Yonemura, Y. (2002) · International Journal of Cancer · doi:10.1002/ijc.10242 · Cited by 216
Selective Delivery of Adiramycin to a Solid Tumor Using a Polymeric Micelle Carrier System
Yokoyama, M., Okano, T., Sakurai, Y., Fukushima, S., Okamoto, K., & Kataoka, K. (1999) · Journal of drug targeting · doi:10.3109/10611869909085500 · Cited by 213
Tumor targeting based on the effect of enhanced permeability and retention (EPR) and the mechanism of receptor-mediated endocytosis (RME)
Tanaka, T., Shiramoto, S., Miyashita, M., Fujishima, Y., & Kaneo, Y. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.09.050 · Cited by 208
Transferrin-conjugated nanoparticles of Poly(lactide)-d-α-Tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood–brain barrier
Gan, C. W., & Feng, S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.06.053 · Cited by 205
Targeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferrin-modified, cyclodextrin-based particles
Pun, S. H., Tack, F., Bellocq, N. C., Cheng, J., Grubbs, B. H., Jensen, G. S., Davis, M. E., Brewster, M. E., Janicot, M., Janssens, B., et al. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.7.918 · Cited by 201
Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: What should be the policy?
Kateb, B., Chiu, K., Black, K. L., Yamamoto, V. N., Khalsa, B., Ljubimova, J. Y., Ding, H., Patil, R., Portilla‐Arias, J., Modo, M., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.01.105 · Cited by 192
Self-citation
Systemic circulation of poly(l-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for human gene therapy
Ward, C. M., Read, M. L., & Seymour, L. W. (2001) · Blood · doi:10.1182/blood.v97.8.2221 · Cited by 191
Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation
Nakase, I., Lai, H., Singh, N. P., & Sasaki, T. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.09.003 · Cited by 190
Plasmid pORF-hTRAIL and doxorubicin co-delivery targeting to tumor using peptide-conjugated polyamidoamine dendrimer
Han, L., Huang, R., Li, J., Liu, S., Huang, S., & Jiang, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.09.070 · Cited by 190
CORRELATION OF TRANSFERRIN RECEPTOR EXPRESSION WITH HISTOLOGICAL CLASS AND OUTCOME IN NON-HODGKIN LYMPHOMA
Habeshaw, J. A., Lister, T. A., Stansfeld, A. G., & Greaves, M. F. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92191-8 · Cited by 190
Peptide-Conjugated PAMAM for Targeted Doxorubicin Delivery to Transferrin Receptor Overexpressed Tumors
Han, L., Huang, R., Liu, S., et al. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100185f · Cited by 182
Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil.
Wu, J. H., Lu, Y., Lee, A., Pan, X., Yang, X., Zhao, X. B., & Lee, R. J. (2007) · PubMed · Cited by 172
The blood-brain and blood-tumor barriers: A review of strategies for increasing drug delivery
Groothuis, D. R. (2000) · Neuro-Oncology · doi:10.1215/s1522851799000307 · Cited by 168
Inhibition of brain tumor growth by intravenous poly(β- l -malic acid) nanobioconjugate with pH-dependent drug release
Ding, H., Inoue, S., Ljubimov, A. V., Patil, R., Portilla‐Arias, J., Hu, J., Konda, B. M., Wawrowsky, K., Fujita, M., Karabalin, N., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003919107 · Cited by 167
Self-citation
Transferrin Conjugates of Doxorubicin: Synthesis, Characterization, Cellular Uptake, and in Vitro Efficacy||
Kratz, F., Beyer, U., Roth, T. F., Tarasova, N. I., Collery, P., Lechenault, F., Cazabat, A., Schumacher, P., Unger, C., & Falken, U. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970246a · Cited by 156
Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells
Kobayashi, T., Ishida, T., Okada, Y., Ise, S., Harashima, H., & Kiwada, H. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.08.039 · Cited by 153
Systemic p53 Gene Therapy of Cancer with Immunolipoplexes Targeted by Anti-Transferrin Receptor scFv
Xu, L., Tang, W., Huang, C., Alexander, W., Xiang, L., Pirollo, K. F., Rait, A. S., & Chang, E. H. (2001) · Molecular Medicine · doi:10.1007/bf03401962 · Cited by 148
Parvoviral Host Range and Cell Entry Mechanisms
Cotmore, S. F., & Tattersall, P. J. (2007) · Advances in virus research · doi:10.1016/s0065-3527(07)70005-2 · Cited by 148
Sorting and recycling of cell surface receptors and endocytosed ligands: The asialoglycoprotein and transferrin receptors
Ciechanover, A. J., Schwartz, A. L., & Lodish, H. F. (1983) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240230111 · Cited by 147
In vitro and in vivo evaluation of actively targetable nanoparticles for paclitaxel delivery
Xu, Z., Gu, W., Huang, J. C., Sui, H., Zhou, Z., Yang, Y., Zhou, Y., & Li, Y. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.10.009 · Cited by 147
Polyion Complex Micelles with Protein-Modified Corona for Receptor-Mediated Delivery of Oligonucleotides into Cells
Vinogradov, S. V., Batrakova, E. V., Li, S., & Kabanov, A. V. (1999) · Bioconjugate Chemistry · doi:10.1021/bc990037c · Cited by 143
DNA-binding transferrin conjugates as functional gene-delivery agents: synthesis by linkage of polylysine or ethidium homodimer to the transferrin carbohydrate moiety
Wagner, E., Cotten, M. L., Mechtler, K., Kirlappos, H., & Birnstiel, M. L. (1991) · Bioconjugate Chemistry · doi:10.1021/bc00010a006 · Cited by 140
Transferrin receptor-dependent cytotoxicity of artemisinin–transferrin conjugates on prostate cancer cells and induction of apoptosis
Nakase, I., Gallis, B. M., Takatani‐Nakase, T., Oh, S. K. W., Lacoste, E., Singh, N. P., Goodlett, D. R., Tanaka, S., Futaki, S., Lai, H. C., et al. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.09.023 · Cited by 137
Transferrin-conjugated lipid-coated PLGA nanoparticles for targeted delivery of aromatase inhibitor 7α-APTADD to breast cancer cells
Zheng, Y., Yu, B., Weecharangsan, W., Piao, L., Darby, M. V., Mao, Y., Koynova, R. D., Yang, X., Li, H., Xu, S., et al. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.02.008 · Cited by 133
In vitro assessment of transferrin-conjugated liposomes as drug delivery systems for inhalation therapy of lung cancer
Anabousi, S., Bakowsky, U., Schneider, M., Huwer, H., Lehr, C., & Ehrhardt, C. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.07.004 · Cited by 131
Synthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide
Oh, S. K. W., Kim, B. J., Singh, N. P., Lai, H. C., & Sasaki, T. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.08.031 · Cited by 131
The dendritic state
Tomalia, D. A. (2005) · Materials Today · doi:10.1016/s1369-7021(05)00746-7 · Cited by 130
Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy
Xu, L., Pirollo, K. F., & Chang, E. H. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00324-8 · Cited by 128
Immunotherapy of Metastatic Malignant Melanoma by a Vaccine Consisting of Autologous Interleukin 2-Transfected Cancer Cells: Outcome of a Phase I Study
Schreiber, S. C., Kämpgen, E., Wagner, E., Pirkhammer, D., Trcka, J., Korschan, H., Lindemann, A., Dorffner, R., Kittler, H., Kasteliz, F., et al. (1999) · Human Gene Therapy · doi:10.1089/10430349950018382 · Cited by 127
Three-step tumor targeting of paclitaxel using biotinylated PLA-PEG nanoparticles and avidin–biotin technology: Formulation development and in vitro anticancer activity
Pulkkinen, M., Pikkarainen, J. T., Wirth, T., TARVAINEN, T., Haapa‐aho, V., KORHONEN, H., Seppälä, J. V., & Järvinen, K. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.04.018 · Cited by 124
Canine parvovirus-like particles, a novel nanomaterial for tumor targeting
Singh, P. N. P., Destito, G., Schneemann, A., & Manchester, M. (2006) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-4-2 · Cited by 120
Inhibition of Human Acute Lymphoblastic Leukemia Cells by Immunotoxins: Potentiation by Chloroquine
Ramakrishnan, S., & Houston, L. L. (1984) · Science · doi:10.1126/science.6318313 · Cited by 120
Combined Genetic and Chemical Capsid Modifications Enable Flexible and Efficient De- and Retargeting of Adenovirus Vectors
Kreppel, F., Gackowski, J., Schmidt, E., & Kochanek, S. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.03.006 · Cited by 119
A new hydrotropic block copolymer micelle system for aqueous solubilization of paclitaxel
Huh, K. M., Min, H. S., Lee, S. C., Lee, H. J., Kim, S., & Park, K. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.11.008 · Cited by 119
Self-Assembly of a Virus-Mimicking Nanostructure System for Efficient Tumor-Targeted Gene Delivery
Xu, L., Frederik, P. M., Pirollo, K. F., Tang, W., Rait, A. S., Xiang, L., Huang, W., Cruz, I., Yin, Y., & Chang, E. H. (2002) · Human Gene Therapy · doi:10.1089/10430340252792594 · Cited by 117
Receptor Mediated Delivery of Daunomycin Using Immunoliposomes: Pharmacokinetics and Tissue Distribution in the Rat
Huwyler, J., Yang, J., & Pardridge, W. M. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36946-0 · Cited by 116
New folate-functionalized biocompatible block copolymer micelles as potential anti-cancer drug delivery systems
Licciardi, M., Giammona, G., Du, J., Armes, S. P., Tang, Y., & Lewis, A. L. (2006) · Polymer · doi:10.1016/j.polymer.2006.03.014 · Cited by 115
Transferrin-Conjugated Liposome Targeting of Photosensitizer AlPcS4 to Rat Bladder Carcinoma Cells
Derycke, A., Kamuhabwa, A. A. R., Gijsens, A., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh314 · Cited by 115
Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic®P85, anin vitrocell line andin vivobiodistribution studies on rat model
Shah, N., Chaudhari, K., Dantuluri, P., Murthy, R. S. R., & Das, S. (2009) · Journal of drug targeting · doi:10.1080/10611860903046628 · Cited by 114
Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects.
White, S., Taetle, R., Seligman, P. A., Rutherford, M., & Trowbridge, I. S. (1990) · PubMed · Cited by 112
Ligand based dendritic systems for tumor targeting
Agarwal, A., Saraf, S., Asthana, A., Gupta, U. D., Gajbhiye, V., & Jain, N. K. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.09.024 · Cited by 111
Improved tumor-specific immunotoxins in the treatment of CNS and leptomeningeal neoplasia
Johnson, V. G., Wrobel, C. J., Wilson, D., et al. (1989) · Journal of neurosurgery · doi:10.3171/jns.1989.70.2.0240 · Cited by 110
Cell entry by human pathogenic arenaviruses
Rojek, J. M., & Kunz, S. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.01113.x · Cited by 109
Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice
Laske, D. W., Ilercil, O., Akbaşak, A., Youle, R. J., & Oldfield, E. H. (1994) · Journal of neurosurgery · doi:10.3171/jns.1994.80.3.0520 · Cited by 108
Ligand anchored dendrimers based nanoconstructs for effective targeting to cancer cells
Gupta, U. D., Dwivedi, S. K. D., Bid, H. K., Konwar, R., & Jain, N. K. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.04.002 · Cited by 107
Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles
Hong, M., Zhu, S., Jiang, Y., Tang, G., Sun, C. Z., Fang, C., Shi, B., & Pei, Y. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.024 · Cited by 106
Polycefin, a New Prototype of a Multifunctional Nanoconjugate Based on Poly(β- l -malic acid) for Drug Delivery
Lee, B.-S., Fujita, M., Khazenzon, N. M., et al. (2006) · Bioconjugate Chemistry · doi:10.1021/bc0502457 · Cited by 105
Cytotoxic potential of ribonuclease and ribonuclease hybrid proteins.
Rybak, S. M., Saxena, S. K., Ackerman, E. J., et al. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54841-9 · Cited by 99
Transferrin receptor expression by human bladder transitional cell carcinomas
Seymour, G. J., Walsh, M. D., Lavin, M. F., et al. (1987) · Urological Research · doi:10.1007/bf00265663 · Cited by 98
Nanoconjugate based on polymalic acid for tumor targeting
Ljubimova, J. Y., Fujita, M., Khazenzon, N. M., Lee, B.-S., Wachsmann‐Hogiu, S., Farkas, D. L., Black, K. L., & Holler, E. (2007) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2007.01.015 · Cited by 96
Self-citation
Efficient delivery of a Bcl-2-specific antisense oligodeoxyribonucleotide (G3139) via transferrin receptor-targeted liposomes
Chiu, S.-J., Liu, S., Perrotti, D., et al. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.02.011 · Cited by 96
The Use of Nanocarriers for Drug Delivery in Cancer Therapy
Khan, D. R. (2010) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000024 · Cited by 94
Biotinylated transferrin/avidin/biotinylated disulfide containing PEI bioconjugates mediated p53 gene delivery system for tumor targeted transfection
Zeng, X., Sun, Y., Qu, W., Zhang, X., & Zhuo, R. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.02.039 · Cited by 94
Transferrin Receptor-Targeted Liposomes Encapsulating anti-BCR-ABLsiRNA or asODN for Chronic Myeloid Leukemia Treatment
Mendonça, L. S., Firmino, F., Moreira, J. N., de Lima, M. C. P., & Simões, S. (2009) · Bioconjugate Chemistry · doi:10.1021/bc9004365 · Cited by 92
Temozolomide Delivery to Tumor Cells by a Multifunctional Nano Vehicle Based on Poly(β-L-malic acid)
Patil, R., Portilla‐Arias, J., Ding, H., Inoue, S., Konda, B. M., Hu, J., Wawrowsky, K., Shin, P. K., Black, K. L., Holler, E., et al. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0091-0 · Cited by 92
Self-citation
A highly cytotoxic human transferrin-ricin A chain conjugate used to select receptor-modified cells.
Raso, V., & Basala, M. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43579-4 · Cited by 90
Tumor-targeted gene delivery of tumor necrosis factor-α induces tumor necrosis and tumor regression without systemic toxicity
Kircheis, R., Ostermann, E., Wolschek, M. F., Lichtenberger, C., Magin-Lachmann, C., Wightman, L., Kursa, M., & Wagner, E. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700487 · Cited by 90
Anti-transferrin receptor antibody linked to Pseudomonas exotoxin as a model immunotoxin in human ovarian carcinoma cell lines.
Pirker, R., FitzGerald, D. J., Hamilton, T. C., et al. (1985) · PubMed · Cited by 89
Tumor regression after systemic administration of a novel tumor-targeted gene delivery system carrying a therapeutic plasmid DNA
Koppu, S., Oh, Y. J., Edrada‐Ebel, R., et al. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.11.015 · Cited by 88
Nanoparticles bearing polyethyleneglycol-coupled transferrin as gene carriers: preparation and in vitro evaluation
Li, Y. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00211-4 · Cited by 88
Transferrin–Liposome-Mediated p53 Sensitization of Squamous Cell Carcinoma of the Head and Neck to Radiation In Vitro
Xu, L., Pirollo, K. F., & Chang, E. H. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.4-467 · Cited by 88
Efficacy of dendrimer‐mediated angiostatin and TIMP‐2 gene delivery on inhibition of tumor growth and angiogenesis: In vitro and in vivo studies
Vincent, L., Varet, J., Pille, J., Bompais, H., Opolon, P., Maksimenko, A., Malvy, C., Mirshahi, M., Lu, H., Vannier, J., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11105 · Cited by 88
Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer.
Yang, D. C., Wang, F., Elliott, R. L., & Head, J. F. (2001) · PubMed · Cited by 87
A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene
Yu, W. H., Pirollo, K. F., Rait, A. S., Yu, B., Xiang, L., Huang, W.-Q., Zhou, Q., Ertem, G., & Chang, E. H. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302304 · Cited by 86
Intraventricular Immunotoxin Therapy for Leptomeningeal Neoplasia
Laske, D. W., Muraszko, K. M., Oldfield, E. H., DeVroom, H. L., Sung, C., Dedrick, R. L., Simon, T. R., Colandrea, J., Copeland, C., Katz, D., et al. (1997) · Neurosurgery · doi:10.1097/00006123-199711000-00005 · Cited by 86
Transferrin receptor expression in tumours of the human nervous system: relation to tumour type, grading and tumour growth fraction
Prior, R., Reifenberger, G., & Wechsler, W. (1990) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01600299 · Cited by 86
Overcoming cisplatin resistance of ovarian cancer cells by targeted liposomes in vitro
Krieger, M. L., Eckstein, N., Schneider, V., Koch, M., Royer, H., Jaehde, U., & Bendas, G. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.12.061 · Cited by 84
An anti-transferrin receptor-avidin fusion protein exhibits both strong proapoptotic activity and the ability to deliver various molecules into cancer cells
Ng, P. P., Cruz, J. S. D., Sorour, D. N., Stinebaugh, J. M., Shin, S.-U., Shin, D. S., Morrison, S. L., & Penichet, M. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162362999 · Cited by 83
Self-citation
Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds
Lai, H. C., Sasaki, T., & Singh, N. P. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.5.995 · Cited by 82
Adriamycin(hydrazone)-antibody conjugates require internalization and intracellular acid hydrolysis for antitumor activity
Braslawsky, G. R., Kadow, K. F., Knipe, J. O., et al. (1991) · Cancer Immunology Immunotherapy · doi:10.1007/bf01741596 · Cited by 82
Transferrin Receptor Expression in Adenocarcinoma of the Lung as a Histopathologic Indicator of Prognosis
Kondo, K., Noguchi, M., Mukai, K., Matsuno, Y., Sato, Y., Shimosato, Y., & Monden, Y. (1990) · CHEST Journal · doi:10.1378/chest.97.6.1367 · Cited by 82
Delivery of antisense oligonucleotides to leukemia cells by RNA bacteriophage capsids
Wu, M., Sherwin, T., Brown, W. L., et al. (2005) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2004.11.011 · Cited by 82
Single-chain immunotoxins directed at the human transferrin receptor containing Pseudomonas exotoxin A or diphtheria toxin: anti-TFR(Fv)-PE40 and DT388-anti-TFR(Fv).
Batra, J. K., FitzGerald, D. J., Chaudhary, V. K., et al. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.4.2200 · Cited by 80
Synthesis and in Vitro Efficacy of Transferrin Conjugates of the Anticancer Drug Chlorambucil
Beyer, U., Roth, T. F., Schumacher, P. M., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9704661 · Cited by 80
Expression and characterization of recombinant human eosinophil-derived neurotoxin and eosinophil-derived neurotoxin-anti-transferrin receptor sFv.
Newton, D. L., NICHOLLS, P. J., Rybak, S. M., et al. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47081-0 · Cited by 78
Brain tumor tandem targeting using a combination of monoclonal antibodies attached to biopoly(β-l-malic acid)
Fujita, M., Lee, B., Khazenzon, N. M., Penichet, M. L., Wawrowsky, K., Patil, R., Ding, H., Holler, E., Black, K. L., & Ljubimova, J. Y. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.032 · Cited by 77
Self-citation
Transferrinfection: A Highly Efficient Way to Express Gene Constructs in Eukaryotic Cells
Zatloukal, K., Wagner, E., Cotten, M. L., PHILLIPS, S., Plank, C., Steinlein, P., Curiel, D. T., & Birnstiel, M. L. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb21066.x · Cited by 75
Antitumor activity in mice of an immunotoxin made with anti-transferrin receptor and a recombinant form of Pseudomonas exotoxin.
Batra, J. K., Jinno, Y., Chaudhary, V. K., et al. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.21.8545 · Cited by 74
Angiogenin Single-Chain Immunofusions: Influence of Peptide Linkers and Spacers between Fusion Protein Domains
Newton, D. L., Xue, Y. W., Olson, K. A., et al. (1996) · Biochemistry · doi:10.1021/bi951650w · Cited by 74
Humanization of immunotoxins.
Rybak, S. M., Hoogenboom, H. R., Meade, H., et al. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3165 · Cited by 73
Transferrin conjugates of adriamycin are cytotoxic without intercalating nuclear DNA.
Barabás, K., SIZENSKY, J. A., & Faulk, W. P. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50442-2 · Cited by 71
Efficacy of transferrin receptor-targeted immunotoxins in brain tumor cell lines and pediatric brain tumors.
Martell, L. A., Agrawal, A. C., Ross, D. A., & Muraszko, K. M. (1993) · PubMed · Cited by 71
HIF-1α and Cancer Therapy
Koh, M. Y., Spivak-Kroizman, T. R., & Powis, G. (2009) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-78281-0_3 · Cited by 70
Engineering receptor-mediated cytotoxicity into human ribonucleases by steric blockade of inhibitor interaction
Suzuki, M., Saxena, S. K., Boix, E., et al. (1999) · Nature Biotechnology · doi:10.1038/7010 · Cited by 69
Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for Paclitaxel
Danhier, F., Magotteaux, N., Učakar, B., Lecouturier, N., Brewster, M. E., & Véronique Préat, A. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.06.015 · Cited by 67
Polymalic Acid–Based Nanobiopolymer Provides Efficient Systemic Breast Cancer Treatment by Inhibiting both HER2/neu Receptor Synthesis and Activity
Inoue, S., Ding, H., Portilla‐Arias, J., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3093 · Cited by 65
Development of transferrin functionalized poly(ethylene glycol)/poly(lactic acid) amphiphilic block copolymeric micelles as a potential delivery system targeting brain glioma
Ren, W.-H., Chang, J., Yan, C., Qian, X.-M., Long, L., He, B., Yuan, X.-B., Kang, C., Betbeder, D., Sheng, J., et al. (2010) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-010-4106-5 · Cited by 64
Artemisinin-transferrin conjugate retards growth of breast tumors in the rat.
Lai, H. C., Nakase, I., Lacoste, E., et al. (2009) · PubMed · Cited by 64
Recent advances in adult T-cell leukemia therapy: focus on a new anti-transferrin receptor monoclonal antibody
Callens, C., Moura, I. C., Lepelletier, Y., Coulon, S., Renand, A., Dussiot, M., Ghez, D., Benhamou, M., Monteiro, R. C., Bazarbachi, A. A., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404958 · Cited by 62
Transferrin's Mechanism of Interaction with Receptor 1
Hémadi, M., Kahn, P. H., Miquel, G., et al. (2004) · Biochemistry · doi:10.1021/bi030142g · Cited by 59
A Novel Dual-targeted Lentiviral Vector Leads to Specific Transduction of Prostate Cancer Bone Metastases In Vivo After Systemic Administration
Pariente, N., Morizono, K., Virk, M. S., Petrigliano, F. A., Reiter, R. E., Lieberman, J. R., & Chen, I. S. Y. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300271 · Cited by 59
Doxorubicin-gallium-transferrin conjugate overcomes multidrug resistance: evidence for drug accumulation in the nucleus of drug resistant MCF-7/ADR cells.
Wang, F., Jiang, X., Yang, D., et al. (2000) · PubMed · Cited by 58
Immunotoxins in the therapy of cancer: From bench to clinic
Ghetie, V. F., & Vitetta, E. S. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90025-6 · Cited by 58
Inhibition of laminin-8 in vivo using a novel poly(malic acid)-based carrier reduces glioma angiogenesis
Fujita, M., Khazenzon, N. M., Ljubimov, A. V., Lee, B., Virtanen, I., Holler, E., Black, K. L., & Ljubimova, J. Y. (2006) · Angiogenesis · doi:10.1007/s10456-006-9046-9 · Cited by 58
Self-citation
Structural model of phospholipid-reconstituted human transferrin receptor derived by electron microscopy
Fuchs, H., Lücken, U., Tauber, R., Engel, A. H., & Gessner, R. V. (1998) · Structure · doi:10.1016/s0969-2126(98)00124-5 · Cited by 57
Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor
Ng, P. P., Helguera, G. F., Daniels‐Wells, T. R., Lomas, S. Z., Rodríguez, J. A., Schiller, G. J., Bonavida, B., Morrison, S. L., & Penichet, M. L. (2006) · Blood · doi:10.1182/blood-2006-04-020263 · Cited by 56
Self-citation
Gallium compounds as antineoplastic agents
Chitambar, C. R. (2004) · Current Opinion in Oncology · doi:10.1097/01.cco.0000142071.22226.d2 · Cited by 55
In vivo gene delivery to tumor cells by transferrin‐streptavidin‐DNA conjugate
Sato, Y., Yamauchi, N., Takahashi, M., Sasaki, K., Fukaura, J., Neda, H., Fujii, S., Hirayama, M., Itoh, Y., Koshita, Y., et al. (2000) · The FASEB Journal · doi:10.1096/fj.99-1052com · Cited by 55
Characterization of a transferrin-diphtheria toxin conjugate.
O'Keefe, D. O., & Draper, R. K. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)71189-0 · Cited by 54
Tumor Cell Targeting of Transferrin−PEG−TNF-α Conjugate via a Receptor-Mediated Delivery System: Design, Synthesis, and Biological Evaluation
Jiang, Y., Liu, C., Hong, M., et al. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060135f · Cited by 54
A versatile targeting system with lentiviral vectors bearing the biotin‐adaptor peptide
Morizono, K., Xie, Y., Helguera, G. F., Daniels‐Wells, T. R., Lane, T. F., Penichet, M. L., & Chen, I. S. Y. (2009) · The Journal of Gene Medicine · doi:10.1002/jgm.1345 · Cited by 53
Self-citation
Phase I dose-escalation study of tumor necrosis factor-alpha and concomitant radiation therapy.
Hallahan, D. E., Vokes, E. E., Rubin, S. J., et al. (2006) · PubMed · Cited by 53
Genetically engineering transferrin to improve its in vitro ability to deliver cytotoxins
Yoon, D. J., Chu, D. S. H., Ng, C., et al. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.10.006 · Cited by 52
Cloning and cytotoxicity of a human pancreatic RNase immunofusion
Zewe, M., Rybak, S. M., DUBEL, S. J., et al. (1997) · Immunotechnology · doi:10.1016/s1380-2933(97)00070-5 · Cited by 52
Targeting Hypoxia-inducible Factor-1α With Tf–PEI–shRNA Complex via Transferrin Receptor–mediated Endocytosis Inhibits Melanoma Growth
Liu, Y., Tao, J., Li, Y., Yang, J. X., Yu, Y., Wang, M., Xu, X., Huang, C., Huang, W., Dong, J., et al. (2008) · Molecular Therapy · doi:10.1038/mt.2008.266 · Cited by 50
Modulation of doxorubicin resistance in a doxorubicin-resistant human leukaemia cell by an immunoliposome targeting transferring receptor
Suzuki, S., Inoue, K., Hongoh, A., et al. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.340 · Cited by 50
Antineoplastic drugs that interfere with iron metabolism in cancer cells
Head, J. F., Wang, F., & Elliott, R. L. (1997) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(96)00010-6 · Cited by 49
Cyclodextrin Rotaxanes and Polyrotaxanes
Wenz, G., Han, B., & Müller, A. H. E. (2006) · ChemInform · doi:10.1002/chin.200624257 · Cited by 49
Doxorubicin-transferrin conjugate selectively overcomes multidrug resistance in leukaemia cells
Łubgan, D., Jóźwiak, Z., Grabenbauer, G. G., et al. (2008) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-008-0037-2 · Cited by 48
Targeting of sterically stabilised pH-sensitive liposomes to human T-leukaemia cells
FONSECA, C., Moreira, J. N., Ciudad, C. J., PEDROSODELIMA, M., & Simões, S. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.08.012 · Cited by 48
Site-specific expression of transferrin receptor by human colon cancer cells directly correlates with eradication by antitransferrin recombinant immunotoxin.
Shinohara, H., Fan, D., Ozawa, S., et al. (2000) · International Journal of Oncology · doi:10.3892/ijo.17.4.643 · Cited by 48
An Immunotoxin Composed of a Monoclonal Antitransferrin Receptor Antibody Linked by a Disulfide Bond to the Ribosome-Inactivating Protein Gelonin: Potent In Vitro and In Vivo Effects Against Human Tumors 2
Charles F. Scott, Jr., Goldmacher, V. S., Lambert, J. M., et al. (1987) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/79.5.1163 · Cited by 44
Cytotoxic effects of a doxorubicin-transferrin conjugate in multidrug-resistant KB cells
Fritzer, M., Szekeres, T., Szüts, V., Jarayam, H. N., & Goldenberg, H. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02225-2 · Cited by 43
Inclusion of a furin-sensitive spacer enhances the cytotoxicity of ribotoxin restrictocin containing recombinant single-chain immunotoxins
Goyal, A., & Batra, J. K. (2000) · Biochemical Journal · doi:10.1042/bj3450247 · Cited by 43
Transferrin directed delivery of adriamycin to human cells.
Singh, M. S., Atwal, H., & Micetich, R. G. (1998) · PubMed · Cited by 43
Effect of an anti-murine transferrin receptor-ricin A conjugate on bone marrow stem and progenitor cells treated in vitro
Lesley, J., Domingo, D. L., Schulte, R. J., & Trowbridge, I. S. (1984) · Experimental Cell Research · doi:10.1016/0014-4827(84)90583-4 · Cited by 42
Transferrin Receptor Targeted Lipopolyplexes for Delivery of Antisense Oligonucleotide G3139 in a Murine K562 Xenograft Model
Zhang, X., Koh, C. G., Yu, B., et al. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9864-8 · Cited by 41
Cytotoxicity of a transferrin‐adriamycin conjugate to anthracycline‐resistant cells
Fritzer, M., Barabás, K., Szüts, V., Bérczi, A., Szekeres, T., Faulk, W. P., & Goldenberg, H. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520421 · Cited by 41
Conjugation of an anti–transferrin receptor IgG3-avidin fusion protein with biotinylated saporin results in significant enhancement of its cytotoxicity against malignant hematopoietic cells
Daniels‐Wells, T. R., Ng, P. P., Delgado, T., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0330 · Cited by 40
Intratumoral Therapy of Glioblastoma Multiforme Using Genetically Engineered Transferrin for Drug Delivery
Yoon, D. J., Kwan, B. H., Chao, F. C., Nicolaides, T. P., Phillips, J. J., Lam, G. Y., Mason, A. B., Weiss, W. A., & Kamei, D. T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4311 · Cited by 39
Correlation of transferrin receptor expression with histologic grade and immunophenotype in chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
Gupta, A. D., & Vi, S. (1990) · PubMed · Cited by 39
Enhanced cytotoxicity of an anti-transferrin receptor IgG3-avidin fusion protein in combination with gambogic acid against human malignant hematopoietic cells: functional relevance of iron, the receptor, and reactive oxygen species
Ortíz-Sánchez, E., Daniels‐Wells, T. R., Helguera, G. F., et al. (2008) · Leukemia · doi:10.1038/leu.2008.270 · Cited by 38
Self-citation
ABT-737 Overcomes Resistance to Immunotoxin-Mediated Apoptosis and Enhances the Delivery of Pseudomonas Exotoxin–Based Proteins to the Cell Cytosol
Traini, R., Ben-Josef, G., Pastrana, D. V., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0257 · Cited by 38
Antitransferrin receptor antibody-RNase fusion protein expressed in the mammary gland of transgenic mice
Newton, D. L., Pollock, D. P., DiTullio, P., et al. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(99)00154-4 · Cited by 37
Adriamycin Conjugates of Human Transferrin Bind Transferrin Receptors and Kill K562 and HL60-Cells
Berczi, A., Barabás, K., SIZENSKY, J. A., et al. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1048 · Cited by 35
Development of Transferrin-Polycation/DNA Based Vectors for Gene Delivery to Melanoma Cells
Wightman, L., Patzelt, E., Wagner, E., & Kircheis, R. (1999) · Journal of drug targeting · doi:10.3109/10611869909085512 · Cited by 35
Potent cytotoxicity of an antihuman transferrin receptor-ricin A-chain immunotoxin on human glioma cells in vitro.
Recht, L. D., Griffin, T. W., Raso, V., & Salimi, A. R. (1990) · PubMed · Cited by 35
An Antibody-based Multifaceted Approach Targeting the Human Transferrin Receptor for the Treatment of B-cell Malignancies
Daniels‐Wells, T. R., Ortíz-Sánchez, E., Lurı́a-Pérez, R., et al. (2011) · Journal of Immunotherapy · doi:10.1097/cji.0b013e318222ffc8 · Cited by 34
Heterogeneous response of individual multicellular tumour spheroids to immunotoxins and ricin toxin
Chignola, R., Foroni, R. I., Franceschi, A., Pasti, M., Candiani, C., Anselmi, C., Fracasso, G., Tridente, G., & Colombatti, M. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.381 · Cited by 33
Inhibition of transplasma membrane electron transport by transferrin-adriamycin conjugates
SUN, I. L., Sun, E. E., Crane, F. L., Morré, D. J., & Faulk, W. P. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90165-i · Cited by 33
A chimeric saporin‐transferrin conjugate compared to ricin toxin: role of the carrier in intracellular transport and toxicity
Ippoliti, R., Lendaro, E., D'Agostino, I., Fiani, M. L., Guidarini, D., Vestri, S., Benedetti, P. A., & Brunori, M. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.12.7672515 · Cited by 33
Preliminary evaluation of platinum transferrin (MPTC-63) as a potential nontoxic treatment for breast cancer.
Elliott, R. L., STJERNHOLM, R. L., & Elliott, M. C. (1988) · PubMed · Cited by 33
Receptor-Targeted Transfection Using Stable Maleimido-Transferrin/Thio-Poly-L-Lysine Conjugates
Taxman, D. J., Lee, E. S., & Wojchowski, D. M. (1993) · Analytical Biochemistry · doi:10.1006/abio.1993.1391 · Cited by 30
(Strept)avidin-displaying lentiviruses as versatile tools for targeting and dual imaging of gene delivery
Kaikkonen, M. U., Lesch, H. P., Pikkarainen, J. T., Räty, J. K., Vuorio, T., Huhtala, T., Taavitsainen, M., Laitinen, T., Tuunanen, P. I., Gröhn, O. H. J., et al. (2009) · Gene Therapy · doi:10.1038/gt.2009.47 · Cited by 29

Sorted by citations

Iron and cancer: more ore to be mined
Torti, S. V., & Torti, F. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3495 · Cited by 1,621
Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery
Nicolas, J., Mura, S., Brambilla, D., Mackiewicz, N., & Couvreur, P. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35265f · Cited by 1,270
Nanomedicine therapeutic approaches to overcome cancer drug resistance
Markman, J. L., Rekechenetskiy, A., Holler, E., & Ljubimova, J. Y. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.019 · Cited by 733
“These therapeutic antibodies, as well as targeting antibodies such as 2C5 [2] and anti-transferrin receptor mAbs [99-101], can be conjugated to various nanoparticles to improve efficacy and increase binding affinity to the cancer cells.”
BackgroundSelf-citation
Lipocalin 2: an emerging player in iron homeostasis and inflammation
Xiao, X., Yeoh, B. S., & Vijay-Kumar, M. (2017) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071816-064559 · Cited by 426
Ligand-installed nanocarriers toward precision therapy
Mi, P., Cabral, H., & Kataoka, K. (2020) · Advanced Materials · doi:10.1002/adma.201902604 · Cited by 350

See all 807

Authors: Daniels, T. R., Bernabeu, E., Rodríguez, J. A., Patel, S., Kozman, M., Chiappetta, D. A., Holler, E., Ljubimova, J. Y., Helguera, G., & Penichet, M. L.
Affiliations: Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
University of California, Los Angeles (US)
Cedars-Sinai Medical Center (US)
Corresponding author: Helguera, Gustavo
Penichet, Manuel L.
ORCID: Bernabeu, Ezequiel
Rodríguez, José A.
Patel, Shabnum
Chiappetta, Diego A.
Holler, Eggehard
Ljubimova, Julia Y.
Helguera, Gustavo
Penichet, Manuel L.
Venue: Biochimica et Biophysica Acta (BBA) - General Subjects
Publisher: Elsevier BV
Published: 2012-03
Volume: 1820
Issue: 3
Pages: 291-317
ISSN: 0304-4165 (ISSN-L)
DOI: 10.1016/j.bbagen.2011.07.016
PMC: PMC3500658
OpenAlex: W2027437657
Cited by: 807
References: 232
Citations by year: 2026: 37 · 2025: 50 · 2024: 69 · 2023: 55 · 2022: 57 · 2021: 65 · 2020: 69 · 2019: 75 · 2018: 64 · 2017: 52 · 2016: 59 · 2015: 55 · 2014: 39 · 2013: 47 · 2012: 14
FWCI: 1.91
Type: journal article
Language: en
Open access: green
hdl.handle.net
Licence: other-oa
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Biochimica et Biophysica Acta (BBA) - General Subjects (publishedVersion)
PubMed (publishedVersion)
Conicet (publishedVersion, other-oa)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
CONICET Digital (CONICET) (submittedVersion, cc-by-nc-nd)
Funders: NIH/NCI (R01CA136841, R01CA107023, R01CA123495, R01CA57152, U01CA151815, K01CA138559)
Howard Hughes Medical Institute Gilliam Fellowship
Whitcome Fellowship of the Molecular Biology Institute at UCLA
National Agency for Promotion of Science and Technology (ANPCyT-FONARSEC PICT-PRH 2008-00315)
Topics: Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords: transferrin receptor, targeted cancer therapy, receptor-mediated drug delivery, transferrin, nanoparticles, viral vectors, iron absorption, cancer cell death
MeSH terms: Antibodies, Monoclonal, Antineoplastic Agents, Carrier Proteins, Genetic Vectors, Humans, Iron, Neoplasms, Receptors, Transferrin, Drug Delivery Systems, Apoptosis, Molecular Targeted Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The transferrin receptor and the targeted delivery of therapeutic agents against cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks